The synthesis of a new series of long-chain arylpiperazine as serotoninergic ligands (FG 1-18) is described. The combination of structural elements including heterocyclic nucleus, propyl chain, and 4,5-dihydrothiazol-2-ylphenylpiperazines leads to the preparation of different derivatives tested for their affinity toward 5-HT1A, 5-HT2A, and 5-HT2C receptors. The compounds with better affinity and selectivity binding profiles toward 5-HT1A and 5-HT2C (FG-1, FG-4, FG-5, FG-6, FG-7, FG-8, and FG-18) are selected for further in vivo assays to determine their functional activity. Finally, to rationalize the obtained results, molecular docking studies are performed. The results of pharmacological studies show that compounds FG-1, FG-5, FG-8, and FG-6 exert antidepressant-like effects, and FG-1, FG-18, FG-6, and FG-7 reveal also significant anxiolytic properties. Among the developed derivatives, the most promising compounds seem to be FG-1, which exhibit antidepressant, anxiolytic, and anticonvulsant properties, FG-7 and FG-18 that show features as anxiolytic combine to a pro-cognitive property and notable affinity and selectivity for 5-HT2C receptor, respectively.
Read full abstract Year 

Publisher 

Journal 

Institution 

1
Institution Country 

Publication Type 

Field Of Study 

Topics 

Open Access 

Language 

Reset All
Cancel
Year 

Publisher 

Journal 

Institution 

1
Institution Country 

Publication Type 

Field Of Study 

Topics 

Open Access 

Language 

Reset All